Imagion Biosystems (ASX:IBX) 3-Year Revenue Growth Rate : 59.90% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Imagion Biosystems 3-Year Revenue Growth Rate?

Imagion Biosystems's Revenue per Share for the six months ended in Dec. 2023 was A$0.02.

During the past 12 months, Imagion Biosystems's average Revenue per Share Growth Rate was 164.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 59.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Imagion Biosystems was 59.90% per year. The lowest was -35.20% per year. And the median was 6.20% per year.

Competitive Comparison of Imagion Biosystems's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Imagion Biosystems's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imagion Biosystems's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Imagion Biosystems's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Imagion Biosystems's 3-Year Revenue Growth Rate falls into.

Imagion Biosystems 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Imagion Biosystems (ASX:IBX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Imagion Biosystems 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Imagion Biosystems's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Imagion Biosystems (ASX:IBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Imagion Biosystems Ltd (ASX:IBX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

5601 Oberlin Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.imagionbiosystems.com

Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

Imagion Biosystems (ASX:IBX) Headlines

No Headlines